Detail akcie Microbot Medical Rg online

Business Summary: Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Microbot Medical Inc revenues was not reported. Net loss increased 20% to $9.7M. Higher net loss reflects General and administrative increase of 65% to $5.9M (expense), Research and development increase of 2% to $4.7M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.53 to -$0.25.